CVS Health Co. (NYSE:CVS) Shares Purchased by Cypress Capital Group

Cypress Capital Group lifted its stake in shares of CVS Health Co. (NYSE:CVS) by 5.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,654 shares of the pharmacy operator’s stock after purchasing an additional 320 shares during the quarter. Cypress Capital Group’s holdings in CVS Health were worth $418,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the company. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the third quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new position in CVS Health during the third quarter valued at $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health in the third quarter worth approximately $32,000. First Community Trust NA increased its stake in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the 3rd quarter valued at approximately $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS opened at $57.07 on Friday. The company has a market capitalization of $71.81 billion, a PE ratio of 14.48, a PEG ratio of 0.94 and a beta of 0.55. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock’s 50 day moving average price is $59.20 and its 200-day moving average price is $58.60. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the business earned $2.21 earnings per share. The company’s quarterly revenue was up 6.3% on a year-over-year basis. On average, equities analysts anticipate that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.66%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Deutsche Bank Aktiengesellschaft lowered their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $60.00 to $66.00 in a research note on Monday. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Barclays reduced their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Finally, Evercore ISI lifted their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $72.28.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.